The Bridge Research Consortium (BRC) is pleased to be partnering with the Canadian Public Health Association and Immunize Canada on a series of webinars focused on supporting public trust and equitable access to vaccine and immune-based innovation in Canada.

Webinar Description
Research and vaccine development using mRNA technology enabled a rapid response to the new pathogen, SARS-CoV-2 early in the COVID-19 pandemic. Yet despite their scientific success, mRNA vaccines have been divisive, and public receptivity to vaccination has waned. This webinar will feature work underway through the BRC Dialogue Platform, drawing lessons from the mRNA COVID-19 vaccine experience to explore what it will take to build and sustain public trust in therapeutic innovations that play a pivotal role in limiting the scale and impact of harm from emerging pathogens. Dr. Plamondon will share highlights from the current dialogue series and reflect on how this responsive, collaborative approach to learning can itself help strengthen trust.